| Allosteric modulators of HSP90 and HSP70: dynamics meets function through structure-based drug design M Ferraro, I D’Annessa, E Moroni, G Morra, A Paladino, S Rinaldi, ... Journal of medicinal chemistry 62 (1), 60-87, 2018 | 93 | 2018 |
| Rational design of allosteric and selective inhibitors of the molecular chaperone TRAP1 C Sanchez-Martin, E Moroni, M Ferraro, C Laquatra, G Cannino, ... Cell reports 31 (3), 2020 | 77 | 2020 |
| Diaryl urea: a privileged structure in anticancer agents L Garuti, M Roberti, G Bottegoni, M Ferraro Current medicinal chemistry 23 (15), 1528-1548, 2016 | 67 | 2016 |
| Design, synthesis, structure–activity relationship studies, and three-dimensional quantitative structure–activity relationship (3D-QSAR) modeling of a series of o-biphenyl … A De Simone, D Russo, GF Ruda, A Micoli, M Ferraro, RMC Di Martino, ... Journal of medicinal chemistry 60 (6), 2287-2304, 2017 | 35 | 2017 |
| Honokiol bis-dichloroacetate is a selective allosteric inhibitor of the mitochondrial chaperone TRAP1 C Sanchez-Martin, D Menon, E Moroni, M Ferraro, I Masgras, J Elsey, ... Antioxidants & Redox Signaling 34 (7), 505-516, 2021 | 31 | 2021 |
| Impact of mutations on NPAC structural dynamics: mechanistic insights from MD simulations M Montefiori, S Pilotto, C Marabelli, E Moroni, M Ferraro, SA Serapian, ... Journal of Chemical Information and Modeling 59 (9), 3927-3937, 2019 | 31 | 2019 |
| Mapping cholesterol interaction sites on serotonin transporter through coarse-grained molecular dynamics M Ferraro, M Masetti, M Recanatini, A Cavalli, G Bottegoni PloS one 11 (12), e0166196, 2016 | 29 | 2016 |
| Machine learning of allosteric effects: the analysis of ligand-induced dynamics to predict functional effects in TRAP1 M Ferraro, E Moroni, E Ippoliti, S Rinaldi, C Sanchez-Martin, A Rasola, ... The Journal of Physical Chemistry B 125 (1), 101-114, 2020 | 25 | 2020 |
| Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening R Buonfiglio, M Ferraro, F Falchi, A Cavalli, M Masetti, M Recanatini Journal of chemical information and modeling 53 (11), 2792-2797, 2013 | 19 | 2013 |
| Dual binding to orthosteric and allosteric sites enhances the anticancer activity of a TRAP1-targeting drug S Hu, M Ferraro, AP Thomas, JM Chung, NG Yoon, JH Seol, S Kim, H Kim, ... Journal of Medicinal Chemistry 63 (6), 2930-2940, 2020 | 18 | 2020 |
| Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning M Ferraro, S Decherchi, A De Simone, M Recanatini, A Cavalli, ... European Journal of Medicinal Chemistry 188, 111975, 2020 | 18 | 2020 |
| Protein allostery and ligand design: Computational design meets experiments to discover novel chemical probes A Triveri, C Sanchez-Martin, L Torielli, SA Serapian, F Marchetti, ... Journal of Molecular Biology 434 (17), 167468, 2022 | 15 | 2022 |
| Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches M Ferraro, G Colombo Molecules 23 (9), 2256-2270, 2018 | 10 | 2018 |
| Atomistic simulations of the mechanisms of the poorly catalytic mitochondrial chaperone Trap1: Insights into the effects of structural asymmetry on reactivity SA Serapian, E Moroni, M Ferraro, G Colombo ACS Catalysis 11 (14), 8605-8620, 2021 | 9 | 2021 |
| Modeling lipid raft domains containing a mono-unsaturated phosphatidylethanolamine species M Ferraro, M Masetti, M Recanatini, A Cavalli, G Bottegoni RSC Advances 5 (47), 37102-37111, 2015 | 6 | 2015 |
Giovanni BottegoniUniversity of UrbinoVerified email at uniurb.it